WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

Branche Konsumgüter defensiv

5.83 2.1

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.8

Max

5.85

Schlüsselkennzahlen
By Trading Economics
Einkommen	-7.1M
Verkäufe	38M
EPS	-0.232
Gewinnspanne	-18.686

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+10.54 upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-5.2M 188M
Vorheriger Eröffnungskurs	3.73
Vorheriger Schlusskurs	5.83

Nachrichtenstimmung

By Acuity

28%

72%

40 / 151 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Nov. 2024, 22:50 UTC

Heiße Aktien

Stocks to Watch: Nvidia, Intel, Sherwin-Williams, Dow, Nuwellis

1. Nov. 2024, 22:43 UTC

Wichtige Markttreiber

Nvidia, Sherwin-Williams Shares Up on Addition to DJIA

1. Nov. 2024, 22:13 UTC

Wichtige Markttreiber

Chewy Up 5% on S&P MidCap 400 Inclusion

1. Nov. 2024, 21:39 UTC

Ergebnisse

Insurance Company Chubb Projects Up to $300 Million Pre-Tax Loss on Hurricane

2. Nov. 2024, 13:53 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2. Nov. 2024, 13:44 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. Nov. 2024, 13:00 UTC

Ergebnisse

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2. Nov. 2024, 12:58 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. Nov. 2024, 12:48 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2. Nov. 2024, 12:32 UTC

Ergebnisse

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2. Nov. 2024, 12:28 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. Nov. 2024, 12:17 UTC

Ergebnisse

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q EPS $18272.00 >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q BNSF Operating Earnings $1.38B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Berkshire Hathaway Energy Company Operating Earnings $1.63B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Insurance-Underwriting Operating Earnings $750M >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Other Operating Loss $877M >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Insurance-Investment Income Operating Earnings $3.66B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Net $26.25B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Other Controlled Businesses Operating Earnings $3.34B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Non-Controlled Businesses Operating Earnings $199M >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Operating Earnings $10.09B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Investment, Derivative Gains $16.16B >BRKA

2. Nov. 2024, 09:30 UTC

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

10.54% Vorteil

12-Monats-Prognose

Durchschnitt 6.5 USD 10.54%

Hoch 8 USD

Tief 5 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

40 / 151 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Landec Corporation designs, develops, manufactures, and sells differentiated products for food and biomaterials markets. The Company licenses technology applications to partners. Its two operating businesses include Curation Foods, Inc. (Curation Foods) and Lifecore Biomedical, Inc. (Lifecore). Curation Foods is engaged in processing, marketing, and selling of fresh packaged plant-based salads and vegetables. Curation Foods brands include Eat Smart, O Olive Oil & Vinegar, Yucatan & Cabo Fresh Avocado Product, BreatheWay Packaging Technology and Windset. Lifecore is an integrated contract development and manufacturing organization (CDMO) that offers sterile, injectable pharmaceutical products in syringes and vials. Lifecore also manufactures pharmaceutical-grade sodium hyaluronate (HA). Its services include technology development, material component changes, analytical method development and formulation development.